IQVIA Strengths, Domain Expertise, and Key Differentiators
IQVIA is a leading global provider of information, innovative technology solutions and contract research services focused on helping healthcare clients find better solutions for patients. Formed through the merger of IMS Health and Quintiles, IQVIA applies human data science, leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science, to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation, and accelerate improvements in healthcare outcomes.
IQVIA Recent Developments
In July 2020, IQVIA partnered with AstraZeneca to accelerate development of a potential new vaccine for COVID-19. The specific IQVIA and AstraZeneca collaboration will drive faster delivery of clinical studies in the U.S. aimed at demonstrating efficacy of AstraZeneca’s potential COVID-19 vaccine.
In April 2020, IQVIA partnered with the UK Governement. IQVIA will provide a single research platform across the United Kingdom to facilitate multiple clinical trials regardless of sponsor. This strategic alliance will examine the effectiveness of repurposed medicines, potential new drugs, and unlicensed therapies for treating COVID-19 patients.
In June 2018, IQVIA has launched IQVIA ePromo, a new cloud-based content management technology solution. ePromo makes it easier for life sciences companies to manage their regulated promotional and medical materials across the entire content cycle of creation, approval, dissemination, and withdrawal.
IQVIA Mergers and Acquisitions (M&A) Activities
IQVIA was formed with the merger of Quintiles and IMS Health in 2016.
IQVIA Customers in ARTW Customer Database
Leveraging a rigorous data-centric research methodology, APPS RUN THE WORLD asks the simple question: Who’s buying IQVIA applications and why? And we provide the answers – supported by decades of research – to our clients around the world. Our Customer database has over 100 data fields that detail company usage of IQVIA and other enterprise apps by function, customer size, industry, location, implementation status, partner involvement, Line of Business Key Stakeholders and IT decision makers contact details. List of Verified IQVIA CORE, IQVIA ePromo, Nexxus Mobile Intelligence CRM, IQVIA OCE Sales customers.
Ownership: - NYSE: IQV
Number of Employees: 67000
IQVIA Key Enterprise and Cloud Applications
IQVIA CORE, IQVIA ePromo, Nexxus Mobile Intelligence CRM, IQVIA OCE Sales
IQVIA Revenues, $M:
|Type/Year||2018||2019||YoY Growth, %|
|Total Revenues, $M||Subscribe||Subscribe||Subscribe|
|Enterprise Applications Revenues, $M||Subscribe||Subscribe||Subscribe|
|Cloud Applications Revenues, $M||Subscribe||Subscribe||Subscribe|
* Enterprise Applications Revenues = License + Support & Maintenance + SaaS
** All revenue figures are estimates based on public records, Cloud and Non-Cloud business models in Apps Run The World's vendor database, and annual survey results including vendor feedback.
IQVIA Revenue Breakdown By Type, $M:
|Type||License||Services||Hardware||Support & Maintenance||SaaS|
|% of Total Revenues||Subscribe||Subscribe||Subscribe||Subscribe||Subscribe|
IQVIA Enterprise Applications Revenues By Functional Markets, $M:
IQVIA Enterprise Applications Revenues By Verticals, $M:
IQVIA Revenues By Region, $M
|Region||% of Total Revenues||2019 Total Revenues, $M||2019 Enterprise Applications Revenues, $M||2019 Cloud Applications Revenues, $M|
IQVIA Direct vs Indirect sales
|Region||Direct Sales||Indirect Sales||Total|
IQVIA Customers - Breakdown by Geo, Size, Vertical and Product
No. of IQVIA Customers: x
No. of IQVIA Enterprise Applications Customers: x
No. of IQVIA Cloud Customers: x
No. of IQVIA Cloud Subscribers: x
IQVIA sells to companies in life sciences, including pharmaceutical companies, biotechnology companies, device and diagnostic companies, and consumer health companies. Nearly all of the top 100 global pharmaceutical and biotechnology companies, measured by revenue, are clients, and many of these companies subscribe to reports and services in many countries. Other clients include payers, government and regulatory agencies, providers, pharmaceutical distributors, and pharmacies.
IQVIA Market Opportunities, M&A and Geo Expansions
In May 2020, IQVIA launched HCP/O Engagement Management, the industry’s first end-to-end, orchestrated healthcare professional/organization (HCP/O) solution that enables the planning, management, contracting, and payment of HCP/Os globally as part of its OCE Suite.
IQVIA's client solutions are powered by the IQVIA CORE. The CORE enables IQVIA to provide customized solutions for clients leveraging the world's largest curated healthcare information source, advanced analytics, leading technologies and extensive industry knowledge across diseases, geographies and scientific methods.
It fuels the company's approach to human data science, including faster, more predictable clinical development, innovative approaches to generating real-world evidence, machine learning to improve patient care, and strategies for precision commercial engagement. The seamless integration of these elements from a molecule to market enables its customers to drive enhanced value, access and health outcomes around the world.
IQVIA Risks and Challenges
IQVIA finds itself in the midst of a global pandemic that could reshape the life sciences industry for years to come. The question is whether IQVIA will be able to seize the opportunities by partnering with the right pharmaceuticals companies, or spreading itself too thin because of its global reach. The jury is still out whether IQVIA and its customers will prevail in a long-running battle to tackle what is expected to be a series of public health challenges. Another issue is whether IQVIA will resort to expensive acquisitions, which may either turn into a well-timed land grab or a Pyrrhic victory.
IQVIA Ecosystem, Partners, Resellers and SI
IQVIA has a Partnership Program consisting of Technology Partners, Advisory System Integrators, and Marketing Agencies.
Salesforce is IQVIA most significant partner. Salesforce and IQVIA jointly bring to market the following clinical and safety products: Trial Transformation Suite (Clinical Trial Management Suite (CTMS), Risk-Based Monitoring (RBM), Clinical Research Associate (CRA) Central), and the Vigilance Platform.
IQVIA Cloud Infrastructure Insights
Subscribe to read more about:
- IQVIA Public Cloud and Infrastructure (IaaS)
- IQVIA Platform (PaaS)
- IQVIA Application Delivery
- IQVIA Private Cloud and Data Centers
Data used in research reports are derived from publicly available documents, continuous surveys of applications vendors, customers, resellers, Independent Software Vendors, systems integrators and other verifiable sources.
Vendor shares and market forecast results are based on a combination of existing databases as well as demand side and supply side research conducted throughout the year with validation from vendors, customers, channel partners and documentations such as earnings releases and 10Q and 10K filings, vertical industry studies, regional and country-level statistics from public and private institutions(i.e. colleges, universities, government agencies and trade associations).
For additional information on our methodologies, here's the link:https://www.appsruntheworld.com/About Us
Copyright © 2021, APPS RUN THE WORLD